Federal award (BPA CALL, fiscal year 2021)
Recipient: BOOZ ALLEN HAMILTON INC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2020-05-21 to 2021-12-31
Current total value of award: $999836.08
Description: FIRM FIXED PRICE AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)-BIOSIMILAR USER FEE ACT I PROGRAM BIOSIMILAR AND INTERCHANGEABLE PRODUCT EDUCATION, UPTAKE, AND IMPLEMENTATION FDA THREE-WAY-MATCHING INVOICE CLAUSE-COR: NIKISHA.JOYNER@FDA.HHS.